StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Noloon May 14, 2019 5:13pm

91 Views

Post# 29746930

RE:RE:RE:Is that the face Gary did when he saw the numbers of Q1 ?

leSpeculateur wrote: This is exaclty what I'm saying... I would prefer to see Gary on TV then in Market News Release... that doesn't look professional.

From the Genenews website: 'MyCancerRisk Introduces Gary the Prostate to educate consumers about prostate health.

'To educate consumers', not investors. Their words. Why can't we wait juuuuust a little bit longer to learn what plans management has for this marketing campaign? How about letting them explain how they intend to use that character they created before jumping to conclusion?

Bullboard Posts

Unique Battery Metals opportunity in Quebec